Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

A woman developed lupus after taking hydroxyurea for two years.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Clindamycin-loaded nanoparticles effectively treat MRSA-infected wounds and promote healing.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.